Key mediators in the immunopathogenesis of allergic asthma

Sannette Hall, Devendra K. Agrawal

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Asthma is described as a chronic inflammatory disorder of the conducting airways. It is characterized by reversible airway obstruction, eosinophil and Th2 infiltration, airway hyper-responsiveness and airway remodeling. Our findings to date have largely been dependent on work done using animal models, which have been instrumental in broadening our understanding of the mechanism of the disease. However, using animals to model a uniquely human disease is not without its drawbacks. This review aims to examine some of the key mediators and cells of allergic asthma learned from animal models and shed some light on emerging mediators in the pathogenesis allergic airway inflammation in acute and chronic asthma.

Original languageEnglish
Pages (from-to)316-329
Number of pages14
JournalInternational Immunopharmacology
Volume23
Issue number1
DOIs
StatePublished - 2014

Fingerprint

Asthma
Animal Models
Respiratory Hypersensitivity
Airway Remodeling
Airway Obstruction
Eosinophils
Inflammation

All Science Journal Classification (ASJC) codes

  • Immunology
  • Immunology and Allergy
  • Pharmacology

Cite this

Key mediators in the immunopathogenesis of allergic asthma. / Hall, Sannette; Agrawal, Devendra K.

In: International Immunopharmacology, Vol. 23, No. 1, 2014, p. 316-329.

Research output: Contribution to journalArticle

@article{3c8d26e43a0542bcb23684561ea04c25,
title = "Key mediators in the immunopathogenesis of allergic asthma",
abstract = "Asthma is described as a chronic inflammatory disorder of the conducting airways. It is characterized by reversible airway obstruction, eosinophil and Th2 infiltration, airway hyper-responsiveness and airway remodeling. Our findings to date have largely been dependent on work done using animal models, which have been instrumental in broadening our understanding of the mechanism of the disease. However, using animals to model a uniquely human disease is not without its drawbacks. This review aims to examine some of the key mediators and cells of allergic asthma learned from animal models and shed some light on emerging mediators in the pathogenesis allergic airway inflammation in acute and chronic asthma.",
author = "Sannette Hall and Agrawal, {Devendra K.}",
year = "2014",
doi = "10.1016/j.intimp.2014.05.034",
language = "English",
volume = "23",
pages = "316--329",
journal = "International Immunopharmacology",
issn = "1567-5769",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Key mediators in the immunopathogenesis of allergic asthma

AU - Hall, Sannette

AU - Agrawal, Devendra K.

PY - 2014

Y1 - 2014

N2 - Asthma is described as a chronic inflammatory disorder of the conducting airways. It is characterized by reversible airway obstruction, eosinophil and Th2 infiltration, airway hyper-responsiveness and airway remodeling. Our findings to date have largely been dependent on work done using animal models, which have been instrumental in broadening our understanding of the mechanism of the disease. However, using animals to model a uniquely human disease is not without its drawbacks. This review aims to examine some of the key mediators and cells of allergic asthma learned from animal models and shed some light on emerging mediators in the pathogenesis allergic airway inflammation in acute and chronic asthma.

AB - Asthma is described as a chronic inflammatory disorder of the conducting airways. It is characterized by reversible airway obstruction, eosinophil and Th2 infiltration, airway hyper-responsiveness and airway remodeling. Our findings to date have largely been dependent on work done using animal models, which have been instrumental in broadening our understanding of the mechanism of the disease. However, using animals to model a uniquely human disease is not without its drawbacks. This review aims to examine some of the key mediators and cells of allergic asthma learned from animal models and shed some light on emerging mediators in the pathogenesis allergic airway inflammation in acute and chronic asthma.

UR - http://www.scopus.com/inward/record.url?scp=84910663190&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84910663190&partnerID=8YFLogxK

U2 - 10.1016/j.intimp.2014.05.034

DO - 10.1016/j.intimp.2014.05.034

M3 - Article

VL - 23

SP - 316

EP - 329

JO - International Immunopharmacology

JF - International Immunopharmacology

SN - 1567-5769

IS - 1

ER -